unilad homepage
unilad homepage
  • News
    • UK News
    • US News
    • World News
    • Crime
    • Health
    • Money
    • Sport
    • Travel
  • Music
  • Technology
  • Film and TV
    • News
    • DC Comics
    • Disney
    • Marvel
    • Netflix
  • Celebrity
  • Politics
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Archive
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
Weight Loss Jab Recommended In The UK
Home>News
Published 10:08 9 Feb 2022 GMT

Weight Loss Jab Recommended In The UK

The NHS is set to offer a weekly injection to help adults struggling with their weight.

Poppy Bilderbeck

Poppy Bilderbeck

google discoverFollow us on Google Discover
Featured Image Credit: Alamy

Topics: UK News

Poppy Bilderbeck
Poppy Bilderbeck

Poppy Bilderbeck is a freelance journalist with words in Daily Express, Cosmopolitan UK, LADbible, UNILAD and Tyla. She is a former Senior Journalist at LADbible Group. She graduated from The University of Manchester in 2021 with a First in English Literature and Drama, where alongside her studies she was Editor-in-Chief of The Tab Manchester. Poppy is most comfortable when chatting about all things mental health, is proving a drama degree is far from useless by watching and reviewing as many TV shows and films as possible.

Advert

Advert

Advert

The NHS could be set to offer a weekly injection to help adults struggling with their weight.

The injection is called Wegovy, and it is made up of a semagultide which helps people eat less by making them feel fuller.

The trial included 1,961 adults who were classified as overweight or obese.

Today NICE has recommended a new treatment option for those living with obesity.

Semaglutide will be made available to adults with at least one weight-related condition and a body mass index (BMI) of at least 35 kg/m2.

Find out more: https://t.co/5GxAje3RoO pic.twitter.com/tksiR1FR2v

— NICE (@NICEComms) February 8, 2022

The participants enrolled in the 'double-blind trial' did not have diabetes, but had a body-mass index of '30 or greater,' as per The New England Journal of Medicine.

In a '2:1 ratio' they were then given '68 weeks of treatment with once-weekly subcutaneous semaglutide or placebo, plus lifestyle intervention'.

Advert

The results showed a drop in body weight of 14.9% in the group taking the Wegovy as opposed to the group who had been given the placebo injection, who dropped 2.4%.

The injection subsequently helped participants lose an average of two stone (13kg).

Injection (Alamy)
Injection (Alamy)

According to the BBC, it has since been recommended by the National Institute for Health and Care Excellence (NICE) that the drug be made available on the NHS.

While the drug has yet to be fully approved, guidelines for England and Wales drafted by NICE state that Wegovy should be 'prescribed by a specialist to obese adults [with] at least one weight-related health condition such as high blood pressure or heart disease, for a maximum of two years'.

The drug can be administered using pre-filled pens and injected by the patient themselves.

Scales (Alamy)
Scales (Alamy)

People classified as obese and who are wanting to lose weight are advised to speak to their GPs as weight loss can be managed through exercise and diet alone.

The study noted other treatments including another injection which is administered daily but with similar effects to the Wegovy, called Saxenda, which contains liraglutide.

Another treatment which makes one feel more full includes the placement of a gastric band around the stomach.

A pill called orlistat stops the absorption of fat from some foods into the blood, and gastric bypass or bariatric surgery focuses on the digestive tract by removing or changing some of the plumbing.

Injection (Alamy)
Injection (Alamy)

In the UK, obesity affects one in four adults. Between 2018-19, England saw 11,117 hospital admissions which were a direct result of obesity.

NICE's Helen Knight concluded: 'We know that management of overweight and obesity is one of the biggest challenges our health service is facing. It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect quality of life.'

If you've been affected by any of the issues in this article and would like to speak with someone in confidence, call the BEAT Eating Disorders helpline on 0808 801 0677. Helplines are open 365 days a year from 9am–8pm during the week, and 4pm–8pm on weekends and bank holidays. Alternatively, you can try the one-to-one webchat 

Choose your content:

11 hours ago
13 hours ago
  • Getty Stock Images
    11 hours ago

    How to tell if you have 'sad nipple' syndrome, according to experts

    While there are no studies available on the condition, there are several theories and suggestions of help.

    News
  • Getty Stock Photo
    11 hours ago

    Putting a dollar bill in your fridge for a one-minute test could save you money, expert says

    The test could save you a lot of cash...

    News
  • Getty Stock Images
    11 hours ago

    M&M's may scrap two iconic colors to become 'Make America Healthy Again' friendly

    M&M’s are set to debut a natural-ingredient version of the iconic candy

    News
  • Getty Stock Photo
    13 hours ago

    Strict no-sex rules at the World Cup explained by experts

    We delve into the science behind the 'famous' rule...

    News
  • Man thought he had trapped gas before nearly dying after weight loss jab mistake
  • First trial of new monthly weight loss jab shows jaw-dropping results compared to Wegovy and Mounjaro
  • Truth behind controversial new weight loss jab 'Reta' that's said to be 3 times stronger than Ozempic
  • Doctor issues urgent advice as hundreds of weight-loss jab users share concerns over diet